SCHEMBL9294039

SCHEMBL9294039

CC1(C)Oc2ccc(S(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2C(N2CCCC2=O)C1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCC9 O60706 11/20 0.59
▸ ABCC8 Q09428 2/20 0.59
▸ KCNJ11 Q14654 2/20 0.59
▸ KCNJ8 Q15842 2/20 0.59
▸ CYP2C9 P11712 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ KCNA5 P22460 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ EPHX2 P34913 1/20 0.36
▸ HTR6 P50406 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9294036 1.00 ABCC9 (0.59) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9294852 0.90 ABCC9 (0.62) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9294853 0.90 ABCC9 (0.62) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9294861 0.90 ABCC9 (0.62) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9294493 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
Rilmakalim SCHEMBL9585284 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9293335 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9294498 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
Rilmakalim SCHEMBL221620 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9
SCHEMBL9293330 0.89 ABCC9 (0.63) ABCC9ABCC8KCNJ11KCNJ8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5364878-A Antiasthmatics; urogenital disorders HOECHST AKTIENGESELLSCHAFT (DE) 1994-11-15 — — US disclosed
EP-0351720-B1 Use of substituted 3,4-dihydro-2H-benzopyrans as medicaments against obstructive disorders of the lung HOECHST AG (DE) 1994-08-24 — — EP disclosed
EP-0560399-A1 Use of substituted 3,4-dihydro-2H-benzopyrans as medicament against disorders of the urethra HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-15 — — EP disclosed
EP-0277612-B1 SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES, PROCESS FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1993-07-28 — — EP disclosed
US-4999371-A Treating Cardiovascular Disorders HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-12 — — US disclosed
EP-0351720-A2 Use of substituted 3,4-dihydro-2H-benzopyrans as medicaments against obstructive disorders of the lung HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-24 — — EP disclosed
EP-0277612-A2 Substituted 3,4-dihydro-2H-benzopyranes, process for their preparation, their use and pharmaceutical preparations based on these compounds HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-10 — — EP disclosed
Send feedback